Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 May;109(1):131–136. doi: 10.1111/j.1476-5381.1993.tb13542.x

Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP.

A Ben-Jebria 1, R Marthan 1, M Rossetti 1, J P Savineau 1
PMCID: PMC2175608  PMID: 7684296

Abstract

1. The effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by the following neuropeptides substance P (SP), neurokinin A (NKA) and vasoactive intestinal peptide (VIP) was studied both in the absence and in the presence of the neutral endopeptidase (NEP) inhibitor, phosphoramidon. 2. Cumulative concentration-response curves (CCRC) to these neuropeptides were constructed in human passively sensitized isolated bronchial rings and compared to those in paired controls. Passively sensitized human isolated bronchial rings were tissues incubated overnight in serum from asthmatic patients atopic to Dermatophagoides pteronyssinus and paired controls were tissues originating from the same lung specimens but incubated overnight in serum from healthy donors. 3. In the absence of phosphoramidon, passive sensitization significantly increased the amplitude of the contractile responses to SP and NKA including that to the maximal concentration given from 50 +/- 5% to 76 +/- 6% (n = 5, P < 0.05) and from 70 +/- 7% to 101 +/- 6% (n = 5, P < 0.05) of the maximal response to acetylcholine, respectively. Passive sensitization significantly shifted to the left the CCRC for both tachykinins as measured by the geometric means dose-ratios which were 8.5 (95% confidence limits (CL): 3.1-13.9) and 7.3 (95% CL: 4.2-10.3) for SP and NKA, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Naline E., Drapeau G., Regoli D. Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur J Pharmacol. 1987 Jul 9;139(2):133–137. doi: 10.1016/0014-2999(87)90244-5. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J. Asthma as an axon reflex. Lancet. 1986 Feb 1;1(8475):242–245. doi: 10.1016/s0140-6736(86)90777-4. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J., Dixon C. M. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Am Rev Respir Dis. 1984 Aug;130(2):162–166. doi: 10.1164/arrd.1984.130.2.162. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J. Neuropeptides in the lung: localization, function, and pathophysiologic implications. J Allergy Clin Immunol. 1987 Feb;79(2):285–295. doi: 10.1016/0091-6749(87)90143-6. [DOI] [PubMed] [Google Scholar]
  5. Barnes P. J. Vasoactive intestinal peptide and asthma. N Engl J Med. 1989 Oct 19;321(16):1128–1129. doi: 10.1056/NEJM198910193211616. [DOI] [PubMed] [Google Scholar]
  6. Black J. L., French R. J., Mylecharane E. J. Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries. Br J Pharmacol. 1981 Nov;74(3):619–626. doi: 10.1111/j.1476-5381.1981.tb10472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Black J. L., Johnson P. R., Armour C. L. Potentiation of the contractile effects of neuropeptides in human bronchus by an enkephalinase inhibitor. Pulm Pharmacol. 1988;1(1):21–23. doi: 10.1016/0952-0600(88)90006-3. [DOI] [PubMed] [Google Scholar]
  8. Black J. L., Marthan R., Armour C. L., Johnson P. R. Sensitization alters contractile responses and calcium influx in human airway smooth muscle. J Allergy Clin Immunol. 1989 Oct;84(4 Pt 1):440–447. doi: 10.1016/0091-6749(89)90356-4. [DOI] [PubMed] [Google Scholar]
  9. Devillier P., Advenier C., Drapeau G., Marsac J., Regoli D. Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. Br J Pharmacol. 1988 Jul;94(3):675–684. doi: 10.1111/j.1476-5381.1988.tb11575.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diamond L., Szarek J. L., Gillespie M. N., Altiere R. J. In vivo bronchodilator activity of vasoactive intestinal peptide in the cat. Am Rev Respir Dis. 1983 Nov;128(5):827–832. doi: 10.1164/arrd.1983.128.5.827. [DOI] [PubMed] [Google Scholar]
  11. Dixon M., Jackson D. M., Richards I. M. The action of sodium cromoglycate on 'C' fibre endings in the dog lung. Br J Pharmacol. 1980 Sep;70(1):11–13. doi: 10.1111/j.1476-5381.1980.tb10898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Evans T. W., Dixon C. M., Clarke B., Conradson T. B., Barnes P. J. Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol. 1988 Feb;25(2):273–275. doi: 10.1111/j.1365-2125.1988.tb03302.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frossard N., Rhoden K. J., Barnes P. J. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther. 1989 Jan;248(1):292–298. [PubMed] [Google Scholar]
  14. Johnson A. R., Ashton J., Schulz W. W., Erdös E. G. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis. 1985 Sep;132(3):564–568. doi: 10.1164/arrd.1985.132.3.564. [DOI] [PubMed] [Google Scholar]
  15. Joos G. F., Pauwels R. A., Van der Straeten M. E. The effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in subjects with asthma. J Allergy Clin Immunol. 1989 Mar;83(3):663–668. doi: 10.1016/0091-6749(89)90080-8. [DOI] [PubMed] [Google Scholar]
  16. Joos G., Pauwels R., van der Straeten M. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax. 1987 Oct;42(10):779–783. doi: 10.1136/thx.42.10.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lammers J. W., Minette P., McCusker M. T., Chung K. F., Barnes P. J. Capsaicin-induced bronchodilation in mild asthmatic subjects: possible role of nonadrenergic inhibitory system. J Appl Physiol (1985) 1989 Aug;67(2):856–861. doi: 10.1152/jappl.1989.67.2.856. [DOI] [PubMed] [Google Scholar]
  18. Lötvall J. O., Elwood W., Tokuyama K., Barnes P. J., Chung K. F. Differential effects of phosphoramidon on neurokinin A- and substance P-induced airflow obstruction and airway microvascular leakage in guinea-pig. Br J Pharmacol. 1991 Dec;104(4):945–949. doi: 10.1111/j.1476-5381.1991.tb12531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mahe L., Chapelain B., Neliat G., Gargouil Y. M. The role of alpha- and beta-adrenoceptors in the response to noradrenaline of lymphatic vessels isolated from the bovine mesentery. Eur J Pharmacol. 1989 Aug 11;167(1):31–39. doi: 10.1016/0014-2999(89)90744-9. [DOI] [PubMed] [Google Scholar]
  20. Marthan R., Armour C. L., Johnson P. R., Black J. L. The calcium channel agonist BAY K8644 enhances the responsiveness of human airway muscle to KCl and histamine but not to carbachol. Am Rev Respir Dis. 1987 Jan;135(1):185–189. doi: 10.1164/arrd.1987.135.1.185. [DOI] [PubMed] [Google Scholar]
  21. Marthan R., Crevel H., Guénard H., Savineau J. P. Responsiveness to histamine in human sensitized airway smooth muscle. Respir Physiol. 1992 Nov;90(2):239–250. doi: 10.1016/0034-5687(92)90084-a. [DOI] [PubMed] [Google Scholar]
  22. Michoud M. C., Jeanneret-Grosjean A., Cohen A., Amyot R. Reflex decrease of histamine-induced bronchoconstriction after laryngeal stimulation in asthmatic patients. Am Rev Respir Dis. 1988 Dec;138(6):1548–1552. doi: 10.1164/ajrccm/138.6.1548. [DOI] [PubMed] [Google Scholar]
  23. Motoyama E. K., Fort M. D., Klesh K. W., Mutich R. L., Guthrie R. D. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1987 Jul;136(1):50–57. doi: 10.1164/ajrccm/136.1.50. [DOI] [PubMed] [Google Scholar]
  24. Naline E., Devillier P., Drapeau G., Toty L., Bakdach H., Regoli D., Advenier C. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis. 1989 Sep;140(3):679–686. doi: 10.1164/ajrccm/140.3.679. [DOI] [PubMed] [Google Scholar]
  25. Palmer J. B., Cuss F. M., Barnes P. J. VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways. J Appl Physiol (1985) 1986 Oct;61(4):1322–1328. doi: 10.1152/jappl.1986.61.4.1322. [DOI] [PubMed] [Google Scholar]
  26. Richardson J., Béland J. Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol. 1976 Nov;41(5 Pt 1):764–771. doi: 10.1152/jappl.1976.41.5.764. [DOI] [PubMed] [Google Scholar]
  27. Savineau J. P., Marthan R., Crevel H. Contraction of vascular smooth muscle induced by phorbol 12,13 dibutyrate in human and rat pulmonary arteries. Br J Pharmacol. 1991 Nov;104(3):639–644. doi: 10.1111/j.1476-5381.1991.tb12482.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shore S. A., Stimler-Gerard N. P., Coats S. R., Drazen J. M. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis. 1988 Feb;137(2):331–336. doi: 10.1164/ajrccm/137.2.331. [DOI] [PubMed] [Google Scholar]
  29. Solway J., Leff A. R. Sensory neuropeptides and airway function. J Appl Physiol (1985) 1991 Dec;71(6):2077–2087. doi: 10.1152/jappl.1991.71.6.2077. [DOI] [PubMed] [Google Scholar]
  30. de Jongste J. C., van Strik R., Bonta I. L., Kerrebijn K. F. Measurement of human small airway smooth muscle function in vitro with the bronchiolar strip preparation. J Pharmacol Methods. 1985 Sep;14(2):111–118. doi: 10.1016/0160-5402(85)90048-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES